Product Code: HLC081E
Highlights:
The global market for sleep aids is estimated to increase from $89.6 billion in 2022 to reach $125.3 billion by 2027, at a compound annual growth rate (CAGR) of 6.9% from 2022 through 2027.
North American market for sleep aids is estimated to increase from $30.0 billion in 2022 to reach $42.1 billion by 2027, at a CAGR of 7.0% from 2022 through 2027.
Asia-Pacific market for sleep aids is estimated to increase from $24.5 billion in 2022 to reach $36.8 billion by 2027, at a CAGR of 8.4% from 2022 through 2027.
Report Scope:
This report offers a detailed picture of the sleep aids market.
This report highlights the current and future market potential for sleep aids and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as key market players.
This report details market shares for sleep aids based on product, sleep disorder and geography. Based on product, the market is segmented into mattresses and pillows, sleep apnea devices, medications, sleep laboratories, and home sleep tests. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS) and others.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2021 through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Report Includes:
- 33 data tables and 37 additional tables
- A comprehensive overview and an up-to-date analysis of the global market for sleep aids
- Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023 and 2025, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for sleep aids, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for global sleep aids market in USD million values, and corresponding market share analysis based on product type, sleep disorder type, and region
- Updated information on market drivers and opportunities for sleep aids industry, key shifts and regulations, technology specific challenges, and other demographic factors affecting the sleep aids market demand over the forecast period (2022-2027)
- Country specific data and market value analysis for the U.S., Canada, Germany, U.K., France, Italy, Spain, Australia, Japan, China, India, South Korea, and other emerging countries
- A comparative study and Porter's Five Forces analysis considering both the micro and macro environmental factors prevailing in the sleep aids market
- Holistic review of the impact of the COVID-19 pandemic and the Russia-Ukraine war on the global market for sleep aids
- Coverage of the technological, economic, and business considerations of the sleep aids market, with global market data analyses and growth forecasts through 2027
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
- Detailed company profiles of the leading market players, including Advanced Brain Monitoring Inc., Ambulatory Monitoring Inc. (AMI), Boehringer Ingelheim GmbH, Fisher & Paykel Healthcare Ltd., Pfizer Inc., and ResMed Inc.
Table of Contents
Chapter 1 Introduction
- 1.1 Introduction
- 1.2 Study Goals and Objectives
- 1.3 Reasons for Doing This Study
- 1.4 Scope of Report
- 1.5 What's New in This Update?
- 1.6 Information Sources
- 1.7 Research Methodology
- 1.8 Geographic Breakdown
- 1.9 Analyst's Credentials
- 1.10 BCC Custom Research
- 1.11 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- 3.1 Overview
- 3.2 Necessity of Sleep
- 3.3 Role of AI in Sleep Aids
- 3.4 Physiology of Normal Sleep
- 3.5 NREM and REM Sleep Cycles
- 3.6 Four Stages of NREM Sleep
- 3.6.1 Stage 1 Sleep
- 3.6.2 Stage 2 Sleep
- 3.6.3 Stages 3 and 4 Sleep
- 3.6.4 REM Sleep
- 3.7 Physiology During Sleep
- 3.8 Newly Recommended Sleep Durations
- 3.9 Mechanism of Action for Different Sleep Drugs
- 3.10 Precautions for Using Sleeping Pills
- 3.11 Treating Insomnia without Prescription Drugs
- 3.11.1 OTC Sleeping Pills
- 3.11.2 OTC Natural Sleep Aids
- 3.12 Current Research Focused on Sleep
- 3.13 NIH Funding for Research on Sleep
- 3.14 Porter's Five Forces Analysis of the Market for Sleep Aids
- 3.14.1 Bargaining Power of Suppliers
- 3.14.2 Bargaining Power of Buyers
- 3.14.3 Threat of New Entrants
- 3.14.4 Threat of Substitutes
- 3.14.5 Degree of Competition
Chapter 4 Impact of COVID-19 and Russia-Ukraine War on the Market
- 4.1 Overview
- 4.2 Impact of COVID-19 on Sleep Aids
- 4.2.1 Stress
- 4.2.2 Anxiety and Depression
- 4.2.3 Social Isolation
- 4.3 Impact of COVID-19 on Sleep
- 4.4 Social Impact of COVID-19
- 4.5 Impact on Insurance Providers
- 4.6 Impact on Health Technology Assement
- 4.7 Impact of COVID-19 and Its Aftermath on the Market for Sleep Aids
- 4.8 Impact of Russia-Ukraine War on the Market for Sleep Aids
Chapter 5 Market Dynamics
- 5.1 Overview
- 5.2 Market Drivers
- 5.2.1 Growing Number of Insomnia Disorders
- 5.2.2 Increasing Prevalence of Obstructive Sleep Apnea (OSA)
- 5.2.3 Increasing Demand for Medication including Herbal Medicines Due to Unhealthy Lifestyles
- 5.2.4 Increase in Geriatric Population Across the World
- 5.3 Market Restraints
- 5.3.1 Side Effects of Medication
- 5.4 Market Opportunities
- 5.4.1 Growing Number of Sleep Aid Product Innovations
- 5.4.2 Opportunities in the Emerging Nations
Chapter 6 Market Breakdown by Product Type
- 6.1 Overview
- 6.1.1 Mattresses and Pillows
- 6.1.2 Sleep Apnea Devices
- 6.1.3 Medications
- 6.1.4 Sleep Laboratories
- 6.1.5 Home Sleep Testing (HST)
Chapter 7 Market Breakdown by Sleep Disorder
- 7.1 Overview
- 7.2 Classification of Sleep Disorders
- 7.3 Polysomnogram Tests
- 7.3.1 Disorders Diagnosed by PSG
- 7.3.2 Equipment Used for the Diagnosis of PSG
- 7.3.3 Results of a PSG
- 7.4 Multiple Sleep Latency Test
- 7.5 Maintenance of Wakefulness Test
- 7.6 Actigraphy Tests
- 7.7 Global Market for Sleep Aids, by Sleep Disorder
- 7.7.1 Insomnia
- 7.7.2 Sleep Apnea
- 7.7.3 Restless Legs Syndrome (RLS)
- 7.7.4 Others
Chapter 8 Market Breakdown by Region
- 8.1 Overview
- 8.2 North America
- 8.2.1 United States
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 United Kingdom
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia-Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia-Pacific
- 8.5 Latin America
- 8.6 Middle East and Africa
Chapter 9 Competitive Landscape
- 9.1 Industry Scenario
- 9.1.1 Opportunity: Emerging Markets
Chapter 10 Company Profiles
- ACTIGRAPH LLC
- ADVANCED BRAIN MONITORING INC.
- AMBULATORY MONITORING INC.
- APNEA SCIENCES CORP.
- BLAIREX LABORATORIES INC.
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- BRAEBON MEDICAL CORP.
- CADWELL LABORATORIES INC.
- CAMNTECH LTD.
- CIRCADIANCE LLC
- CLEVELAND MEDICAL DEVICES INC.
- DRIVE DEVILBISS HEALTHCARE
- FISHER & PAYKEL HEALTHCARE CORP., LTD.
- GLIDEWELL
- HANS RUDOLPH INC.
- MODERN DENTAL LABORATORY USA
- NIHON KOHDEN AMERICA INC.
- PFIZER INC.
- RESMED INC.
Chapter 11 Appendix: List of Acronyms